Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2011

Primary Completion Date

April 1, 2019

Study Completion Date

March 30, 2020

Conditions

Interstitial CystitisPainful Bladder Syndrome

Interventions

DRUG

bupivacaine, triamcinolone, and heparin (BTH)

30mL of 0.5% bupivacaine (5mg/mL), 2mL triamcinolone (10mg/mL), and 2mL Heparin (10,000units/mL)

DRUG

dimethyl sulfoxide (DMSO)

50mL of DMSO and 1mL of triamcinolone (10mg/mL)